Immuneering Corp (NASDAQ:IMRX) showed up in the 13F filings of 90 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 9,697,938 | 12,443 | 0.13% | $51,108,133.00 |
| Sanofi | 31 Mar, 2026 | 2,708,559 | 0 | 0.00% | $14,274,106.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 1,996,585 | 1,284,710 | 180.47% | $10,522,002.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 1,829,188 | 1,829,188 | 0.00% | $9,640.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,507,258 | 55,552 | 3.83% | $7,943,249.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,102,712 | 1,051,789 | 2,065.45% | $5,811,292.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 637,944 | 19,870 | 3.21% | $3,363,708.00 |
| Occam Crest Management LP | 31 Mar, 2026 | 545,098 | 46,600 | 9.35% | $2,872,666.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 447,278 | 356,819 | 394.45% | $2,357,155.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Mar, 2026 | 400,363 | 267,683 | 201.75% | $2,109,913.00 |
| Summit Financial, LLC | 31 Mar, 2026 | 376,749 | 376,749 | 0.00% | $1,985,467.00 |
| UBS Group AG | 31 Mar, 2026 | 376,284 | 185,951 | 97.70% | $1,983,017.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 327,655 | -309,963 | -48.61% | $1,726,742.00 |
| Burkehill Global Management, LP | 31 Mar, 2026 | 300,000 | 0 | 0.00% | $1,581,000.00 |
| Morgan Stanley | 31 Mar, 2026 | 296,067 | -193,550 | -39.53% | $1,560,273.00 |
| State Street Corp | 31 Mar, 2026 | 268,520 | -2,133,718 | -88.82% | $1,415,100.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 244,771 | 37,616 | 18.16% | $1,289,943.00 |
| Squarepoint Ops LLC | 31 Mar, 2026 | 226,046 | 133,790 | 145.02% | $1,191,262.00 |
| Diametric Capital, LP | 31 Mar, 2026 | 174,897 | -71,960 | -29.15% | $921,707.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 156,424 | 156,424 | 0.00% | $824,355.00 |